Galera Therapeutics doubles authorized common stock to 400M shares; adds written consent right

Galera Therapeutics, Inc.

Authorized common stock increased from 200M to 400M shares via charter amendment filed May 11, 2026.
Stockholders approved the stock increase and written consent right at May 8, 2026 annual meeting.
Written consent charter amendment and amended bylaws filed May 12, enabling stockholder action by written consent.

item 5.03item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.